Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prelude Therapeutics Inc

0.7360
+0.02393.36%
Volume:81.67K
Turnover:60.46K
Market Cap:40.51M
PE:-0.42
High:0.7631
Open:0.7120
Low:0.7120
Close:0.7121
Loading ...

Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-Escalation Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib in Patients With Relapsed/Refractory Lymphoid Malignancies

THOMSON REUTERS
·
11 Dec 2024

Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies

GlobeNewswire
·
11 Dec 2024

Prelude Therapeutics price target lowered to $4 from $7 at JMP Securities

TIPRANKS
·
11 Dec 2024

Prelude Therapeutics: Promising Clinical Advancements and Strong Financial Position Drive Buy Rating

TIPRANKS
·
11 Dec 2024

November 2024's Top Picks: Penny Stocks On US Exchanges

Simply Wall St.
·
30 Nov 2024

After Plunging -31.47% in 4 Weeks, Here's Why the Trend Might Reverse for Prelude Therapeutics (PRLD)

Zacks
·
27 Nov 2024

Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit

GlobeNewswire
·
27 Nov 2024

Prelude Therapeutics Reports Progress in Clinical Trials and Financial Health

TIPRANKS
·
26 Nov 2024

Down -39.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Prelude Therapeutics (PRLD)

Zacks
·
11 Nov 2024

Prelude Therapeutics (PRLD) Receives a Sell from Barclays

TIPRANKS
·
08 Nov 2024

Prelude Therapeutics (PRLD) Gets a Sell from Morgan Stanley

TIPRANKS
·
07 Nov 2024

Prelude Therapeutics: Promising Developments and Strategic Collaborations Drive Buy Rating

TIPRANKS
·
07 Nov 2024

Prelude Therapeutics Q3 EPS $(0.43) Beats $(0.47) Estimate

Benzinga
·
07 Nov 2024

BRIEF-Prelude Therapeutics Q3 EPS USD -0.43

Reuters
·
07 Nov 2024

Prelude Therapeutics Inc: Current Cash Runway Into 2026

THOMSON REUTERS
·
07 Nov 2024

Prelude Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview

Reuters
·
28 Oct 2024